Transforming Hematology Care - Empowering Better Cancer Treatment in the 'Europe's Beating Cancer Plan'
Tuesday, 10 October 2023 | 12:30 - 14:00 CET
Cancer concerns us all in various ways, and patients with haematological malignancies, which are cancers that originate in the blood-forming tissue, face specific challenges. According to the European Commission, in 2020 alone, 2.7 million individuals in the European Union received a cancer diagnosis, and 1.3 million lives were lost to the disease. For patients with haematological malignancies, expert treatment is crucial due to the unique nature of their diagnosis.
In 2021, recognising the need for comprehensive cancer care, the European Union introduced the Europe's Beating Cancer Plan, aiming to address the entire cancer pathway. This plan aims to tackle the challenges faced by patients with haematological malignancies, among others, through its four primary areas of action: prevention, early detection, diagnosis and treatment, and improving the quality of life for cancer patients and survivors.
Join this EURACTIV Hybrid Conference to discuss the Europe's Beating Cancer Plan and how the quality of cancer care for patients with haematological malignancies can be improved. Questions to be discussed include:
- What are the challenges faced by patients with hematological malignancies and how is the Europe's Beating Cancer Plan addressing them?
- Due to the nature of hematological diseases there are no specific screening/preventive mechanisms in place. What policies are needed to improve care of hematological diseases in the EU and in Member States?
- What is the role of stakeholders to close the gap for proper diagnosis and access to adequate and timely treatments?
Confirmed speakers are:
Matthias Schuppe, Project Team Leader for Cancer Plan, DG SANTE, European Commission
Nicolás González Casares MEP, Member SANT Committee, European Parliament
Robin Doeswijk, Head of European Affairs, European Hematology Association (EHA)
Natacha Bolaños, Head of Membership & Alliances, Lymphoma Coalition
Richard Price, Head of Policy, European Cancer Organisation (ECO)
Sophie van Tomme, Global Health Value Translation Lead, Sanofi
Find out more.
